By Editor , 12 October 2026
NTT Cuts Microalgae CO2 Measurement Error From 3,300% to 8%

Tokyo – October 12, 2026 -- NTT, Inc. has cut the maximum relative error of sensor-based CO2 absorption monitoring in microalgae cultures from approximately 3,300% to approximately 8%, measured against the conventional titration method.

The technology calculates dissolved inorganic carbon (DIC) concentrations from CO2 and other sensor readings. It does not require sampling the culture fluid for each measurement. The results were published in the journal Algal Research on August 12, 2026.

By Editor , 25 September 2026
Study: 55% of AD Patients Switch Systemic Therapy Over Efficacy Gaps

Friendswood, Texas – September 24, 2026 -- More than half of atopic dermatitis (AD) patients who used targeted systemic therapies modified treatment because the drugs failed to work, according to a new study published in Dermatology and Therapy by Castle Biosciences, Inc. (Nasdaq: CSTL).

By Editor , 21 September 2026
Study: GenAI Use Linked to Higher GPAs, Not Academic Struggle

PHOENIX – September 20, 2026 -- New peer-reviewed research from University of Phoenix found that non-traditional undergraduate students who used generative AI tools more frequently reported higher GPAs and greater confidence in technology skills, contradicting assumptions that GenAI is primarily a crutch for struggling or time-pressed learners.

By Editor , 19 September 2026
Study: Curriculum-Career Alignment Tops Graduate Employability Factors

Phoenix – September 19, 2026 -- A peer-reviewed study of 380 U.S. college graduates has identified curriculum-career alignment as the highest-rated strategy for building employability, ahead of critical thinking training and real-world application opportunities.

By Editor , 19 September 2026
Study Links GLP-1 Weight Loss to Nutrient Gaps Affecting Skin Repair

Beverly Hills -- A peer-reviewed narrative review published September 11, 2026, in Aesthetic Surgery Journal Open Forum identifies nutritional deficiencies as an overlooked factor in skin changes among patients using GLP-1 receptor agonists such as semaglutide and tirzepatide for rapid weight loss.

By Editor , 16 September 2026
Talogy's Caliper Data Anchors New ABA Book on Lawyer Resilience

Pittsburgh – September 15, 2026 -- Lawyers score just 30% on resilience compared with 50% for the general public, a gap that has held steady since 1994, according to 30 years of data from Talogy's Caliper Profile assessment cited in a new American Bar Association book.